Compliance of Antihypertensive Treatment Study
试验速览
- 阶段
- 不适用
- 入组人数
- 1,062
- 主要终点
- the percentage of missed doses, delayed doses, the percentage of correct dosing period and blood pressure
研究概览
简要总结
Study Rational:
In general, chronic disease without symptoms such as hypertension, the treatment compliance is relative low and is difficult to increase. The low compliance is related to poor prognosis. There are many factors that effect to compliance of antihypertensive drug. Education is one factor that can be controlled by doctors. Therefore, in this study, the compliance of the patients in 3 groups of active training group, passive training group, and no training group (usual treatment group) will be compared to evaluate the effect of training for controlling of hypertension.
详细描述
Objectives:
Primary objective - The compliance of each group for the antihypertensive drug is evaluated and compared.
The patients are allocated to three groups; active training group, passive training group, no training group (usual treatment group) and training is performed as described below.
- Active training group: Electronic Pill-Boxes with SMS service 1/week, training material provided
- Passive training group: Electronic Pill-Boxes ,Training material provided
- Usual treatment group: Electronic Pill-Boxes, maintain current treatment method
Secondary objective -
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient diagnosed as hypertension.
- •Hypertension patients diagnosed and treated but not meeting the target blood pressure. (Target blood pressure: SBP<140mmHg and DBP<90mmHg. In case having concomitant disease JNC-VII guideline is followed)
- •Patients age over 18
排除标准
- •Patients with severe chronic disease
- •Patients scheduled for operation within 6 month period.
- •Patients currently participating in other clinical study.
- •Pregnant, nursing patient and patient with potential to be pregnant.
- •Patient who can not or has no intension to participate in compliance check.
结局指标
主要结局
the percentage of missed doses, delayed doses, the percentage of correct dosing period and blood pressure
时间窗: 6 months
次要结局
未报告次要终点